Christoph Lengauer, Chief Scientific Officer at Blueprint Medicines Corp (BPMC), sold 31,119 shares at $25.03 ($780K) on 2015-12-16, disclosed to the SEC on 2015-12-17.
Scheduled sale ($780k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.00 | 500 | $13K | 1.6% |
| 2 | $25.03 | 24,156 | $605K | 77.6% |
| 3 | $25.14 | 6,463 | $162K | 20.8% |
| Total | $25.05 avg | 31,119 | $780K | 100% |
| Filing → |
| BPMC | SELL | 2015-11-04 | $1.8M | — | Filing → |